clinical trial of advanced Ayurvedic topical formulation in chronic plaque psoriasis.
- Conditions
- Health Condition 1: L408- Other psoriasis
- Registration Number
- CTRI/2023/01/048658
- Lead Sponsor
- BVG life Sciences Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Psoriasis area severity index(PASI) of >10% for > 6 months.
2.Body surface involvement (BSI) of >10%.
3.Willing to provide voluntary written informed consent.
4.Patients with the classical features of Chronic Plaque Psoriasis.
5.Patients not taking any other medicine for Chronic Plaque Psoriasis.
1.Pregnant women and lactating mothers.
2.Patients suffering from systemic disorders as Cardiac, renal and hepatic diseases, Uncontrolled Diabetes mellitus, Uncontrolled Hypertension, Paralysis, Malignancy, Human immune deficiency virus infection, HBsAg, Leprosy.
3.Patients suffering from Psoriatic arthritis.
Patients who have received systemic therapy for psoriasis or those who have been treated with immunosuppressive immune - modulating treatment in previous 8 weeks.
4.Patient with personal or family history of malignant or premalignant skin tumours.
5.Subject with active infection either acute or chronic by fungi, viruses bacteria and parasites
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method changes in Psoriasis Area and Severity Index (PASI Score)Timepoint: Baseline,8 weeks,12 weeks
- Secondary Outcome Measures
Name Time Method changes in Dermatology Life Quality Index (DLQI)Timepoint: Baseline,8 weeks,12 weeks